Rottapharm latest to fall victim to periphery 'bloodbath'
Italian drug maker Rottapharm Madaus pulled its IPO on Thursday as the deteriorating conditions across peripheral Europe began to take their first victims.
Unlock this article.
The content you are trying to view is exclusive to our subscribers.
To unlock this article: